Pressure ulcers in the chronically critically ill patient

Critical Care Clinics

Volumn 18, Issue 3, 2002, Pages 683-694

  Brem, Harold ^a   Nierman, David M ^a   Nelson, Judith E ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC DISEASE; CLINICAL EXAMINATION; CLINICAL PROTOCOL; CRITICAL ILLNESS; DEBRIDEMENT; DECISION MAKING; DECUBITUS; DISEASE COURSE; HEALING; HIGH RISK PATIENT; HUMAN; PATHOGENESIS; PATIENT CARE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW;

CHRONIC DISEASE; COMORBIDITY; CRITICAL ILLNESS; DEBRIDEMENT; HUMANS; PRESSURE ULCER; WOUND HEALING;

EID: 0036313919     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0704(02)00014-3     Document Type: Review

References (49)

1. Pressure ulcer prevalence, incidence, risk factors, and impact
2. The epidemiology and natural history of pressure ulcers in elderly nursing home residents
3. Pressure ulcers among the elderly
4. Risk factors for pressure sores in the critically ill
5. The increasing medical malpractice risk related to pressure ulcers in the United States
6. The relationship between pressure ulcer incidence and buttock-seat cushion interface pressure in at-risk elderly wheelchair users
7. Prevalence, risk factors and prevention of pressure ulcers in Dutch intensive care units. Results of a cross-section survey
8. Management of pressure ulcers
9. National prevalence pressure ulcer survey: A benchmarking approach
10. A national study of pressure ulcer prevalence and incidence in acute care hospitals
11. Outcomes in prospective studies and clinical trials
12. High morbidity and hospital costs of stage IV pressure ulcers
13. Definitions and guidelines for assessment of wounds and evaluation of healing
14. Secretory products of macrophages
15. Angiogenesis and basic fibroblast growth factor during wound healing
16. Diagnosis and classification of chronic wounds
17. Regional differences in the growth of normal and neoplastic cells
18. Regional differences in tumor growth: Studies of the vascular system
19. Regional differences in blood flow in relation to tumor growth in the mouse
20. Regional differences in the growth of skin transplants
21. Pressure-relieving strategies for preventing and treating pressure sores
22. Beds, mattresses and cushions for pressure sore prevention and treatment
23. Rate of healing in pressure ulcer wounds measured to complete healing
24. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: A new paradigm in wound healing
25. Overview of wound healing in a moist environment
26. Pressure ulcers: Local wound care
27. An open study comparing topical silver sulfadiazine and topical silver sulfadiazine celium nitrate in the treatment of moderate and severe burns
28. Burn wound infections: Current status
29. Promoter function of the angiogenic inducer Cyr61 gene in transgenic mice: Tissue specificity, inducibility during wound healing, and role of the serum response element
30. Potentiation of cytotoxic cancer therapies by the TNP-470 alone with other antiangiogenic agents
31. Inhibition of tumor angiogenesis
32. Selective endothelial growth inhibition by tetracyclines that inhibit collagenase
33. Angiogenesis inhibition by minocycline
34. Interstitial collagenase is required for angiogenesis in vitro
35. Suppression of human microvascular endothelial cell invasion and morphogenesis with synthetic matrixin inhibitors. Targeting angiogenesis with MMP inhibitors
36. Overexpression of a secretory form of FGF-1 promotes MMP-1-mediated endothelial cell migration
37. A deficit in collagenase activity contributes to impaired migration of aged microvascular endothelial cells
38. Foundations of good ulcer care
39. A review of nonclinical toxicology studies of becaplermin (rhPDGF-BB)
40. Behavior of tissue-engineered skin: A comparison of a living skin equivalent, autograft, and occlusive dressing in human donor sites
41. Healing of venous ulcers of long duration with a bilayed living skin substitute: Results from a general surgery and dermatology department
42. Cultured skin as a "smart material" for healing wounds: Experience in venous ulcers
43. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent
44. Skin: The first tissue-engineered products
45. A bilayered living skin construct (Apligraf) accelerates complete closure of hard-to-heal venous ulcers
46. An economic assessment of Apligraf (Graftskin) for the treatment of hard-to-heal venous leg ulcers
47. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: A prospective randomized multicenter clinical trial
48. Role of nutrition in healing of ninety-six consecutive pressure ulcers